Sofía Pérez-Del-Pulgar
Grupo de investigación
- Enfermedades hepáticas víricas, genéticas e inmuno-mediadas Accredited researcher (R3A-CIBER)
Publicaciones destacadas
-
Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture
Autores:Referencia: Nature Communications 2021. -
Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance
Autores:Referencia: Elife 2021. -
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
Autores:Referencia: Journal Of Hepatology 2021. -
Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantation
Autores:Referencia: Journal Of General Virology 2019. -
Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals.
Autores:Referencia: Journal Of Viral Hepatitis 2018. -
Phylogenetic analysis of an epidemic outbreak of acute hepatitis C in HIV-infected patients by ultra-deep pyrosequencing
Autores:Referencia: Journal Of Clinical Virology 2017. -
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture
Autores:Referencia: Nature Microbiology 2017. -
Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen
Autores:Referencia: Gastroenterology 2016. -
Clinical relevance of the study of hepatitis B virus covalently closed circular DNA
Autores:Referencia: Liver International 2016. -
Hepatitis C virus infection inhibits P-body granule formation in human livers
Autores:Referencia: Journal Of Hepatology 2015.
Proyectos destacados
-
Study of cccDNA persistence during HBV infection in vivo, and in vitro using a bioreactor that mimics the liver microenvironment
Investigador/a principal: Sofia Perez del Pulgar GallartFinanciador: Instituto de Salud Carlos IIICódigo: PI16/00111Duración: 01/01/2017 - 31/12/2019 -
Virological and immunological factors associated with hepatitis C and hepatitis B virus infection recurrence after treatment discontinuation
Investigador/a principal: Xavier Forns BernhardtFinanciador: Gilead EspañaDuración: 07/03/2016 - 06/03/2018 -
TherVacB: A therapeutic vaccine to cure hepatitis B
Investigador/a principal: Xavier Forns BernhardtFinanciador: European CommissionCódigo: 848223Duración: 01/01/2020 - 31/12/2024 -
Interplay between HBV, HDV and host factors: impact on liver disease progression (InBDeL)
Investigador/a principal: Sofia Perez del Pulgar GallartFinanciador: ISCIII ; Instituto de Salud Carlos III (ISCIII)Código: PI19/00036Duración: 01/01/2020 - 31/12/2022 -
Viral and immune factors associated with antiviral treatment and hepatitis C recurrence after liver transplantation
Investigador/a principal: Sofia Perez del Pulgar GallartFinanciador: CIBER ENFERMEDADES HEPATICAS Y DIGESTIVAS (CIBEREHD) (Sede o evento); Instituto de Salud Carlos IIICódigo: PI13/00155Duración: 01/01/2014 - 30/03/2017